首页> 外文期刊>Cardiovascular Research >Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction
【24h】

Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction

机译:封锁NKG2D / NKG2D配体相互作用衰减心肌梗死后的心脏重塑

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Accumulating evidence demonstrates that cardiomyocyte death contributes to the onset and progression of heart failure (HF) after myocardial injury. Recent studies revealed that immune/inflammatory reactions play important roles in cardiovascular diseases. However, it remains unclear whether immunosurveitlance system, which eliminates cytopathic cells, including infected or malignant cancer cells, is involved in cardiomyocyte death, though cardiomyocytes are exposed to pathological stresses during post-infarct remodelling. The aim of this study is to clarify the pathophysiological significance of Natural Killer Group 2 member D (NKG2D)/NKG2D ligand (NKG2DL)-mediated cell death in HF after myocardial infarction (MI).
机译:旨在积累证据表明心肌细胞死亡有助于心肌损伤后心力衰竭(HF)的发病和进展。 最近的研究表明,免疫/炎症反应在心血管疾病中起重要作用。 然而,仍然不明确于免疫尿素系统是否消除了细胞病变细胞,包括感染或恶性癌细胞,涉及心肌细胞死亡,但在梗死后的重塑过程中,心肌细胞暴露于病理应激。 本研究的目的是阐明自然杀手群2成员D(NKG2D)/ NKG2D配体(NKG2DL)介导的细胞死心肌梗死(MI)的病理生理学意义(NKG2D)/ NKG2D配体(NKG2DL)介导的细胞死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号